Author:
Wibmer C.,Amrein K.,Fahrleitner-Pammer A.,Gilg M. M.,Berghold A.,Hutterer G. C.,Maurer-Ertl W.,Gerger A.,Leithner A.,Pichler M.,Szkandera J.
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. van Bezooijen, R. L., ten Dijke, P., Papapoulos, S. E. & Lowik, C. W. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev. 16, 319–327 (2005).
2. Wijenayaka, A. R. et al. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One 6, e25900 (2011).
3. Poole, K. E. et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J. 19, 1842–1844 (2005).
4. Chan, B. Y. et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 19, 874–885 (2011).
5. Hughes, J. M. & Petit, M. A. Biological underpinnings of Frost’s mechanostat thresholds: the important role of osteocytes. J. Musculoskelet. Neuronal Interact. 10, 128–135 (2010).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献